The available evidence from randomized placebo-controlled clinical trials in adults with autoimmune disease conditions does not support the risk of active tuberculosis or herpes zoster with TNF inhibitors. However, the evidence is insufficient for strong conclusions.
Okoli et al. (Fri,) studied this question.